TransCode Therapeutics Expands Leadership with Appointment of Jack E. Stover to Board of Directors

TransCode Therapeutics, Inc. (NASDAQ: RNAZ), a clinical stage company pioneering immuno-oncology and RNA for the treatment of high risk and advanced cancer, announced the appointment of Jack E. Stover ...
TipRanks on MSN

TransCode Therapeutics strengthens board with veteran financial expert

TransCode Therapeutics ( ($RNAZ) ) just unveiled an announcement. On December 19, 2025, TransCode Therapeutics appointed veteran life sciences ...
Yahoo Finance

TransCode Therapeutics Awarded $2 Million NIH Grant to Support Clinical Evaluation of Lead Candidate

BOSTON, Sept. 05, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced ...

Investornewsbreaks Transcode Therapeutics, Inc. (NASDAQ: RNAZ) Appoints Jack E. Stover To Board Of Directors

Appoints Jack E. Stover To Board Of Directors. TransCode Therapeutics (NASDAQ: RNAZ) announced the appointment of Jack E. Stover to its Board of Directors, where he will serve on the Audit Committee ...
TWCN Tech News

How to Transcode a Video using free Video Transcoder in Windows 11

Video transcoding is basically the process of converting videos from one digital encoding format to another. You can also call it Video encoding. This process involves converting the video file format ...
Yahoo Finance

TransCode Therapeutics Withdraws Public Offering

BOSTON, Oct. 30, 2023 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ) (the “Company”), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, ...
FierceBiotech

TransCode rewrites future, securing $25M lifeline and phase 3 cancer vaccine

In a pair of deals, TransCode Therapeutics has bagged Polynoma and its phase 3 cancer vaccine, as well as a $25 million injection into its cash-strapped coffers—but in doing so, the company is trading ...
Pharmabiz

TransCode begins patient dosing in Cohort 4 of phase 1 trial with TTX-MC138 to treat metastatic cancer

TransCode Therapeutics, Inc., the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, announced that the first patient in Cohort 4 of its phase I clinical trial ...
Investing

Transcode Therapeutics stock hits 52-week low at $1.7

Transcode Therapeutics, Inc. (RNAZ) stock has reached a 52-week low, trading at $1.7, marking a significant downturn for the biotech company. With a market capitalization of just $1.25 million, ...
Liliputing

Media transcoding is coming to the Microsoft PowerToys Advanced Paste tool (transcode audio and video from a copy/paste context menu)

Microsoft PowerToys is a free application that brings a bunch of advanced features to Windows for power users. Some of those tools give you more control over your mouse and keyboard settings. Others ...
Investing

TransCode Therapeutics appoints Jack E. Stover to board of directors

BOSTON - TransCode Therapeutics, Inc. (NASDAQ:RNAZ), a clinical stage company focused on immuno-oncology and RNA treatments for advanced cancer, announced Monday the appointment of Jack E. Stover to ...